Our most well-respected scientific research validates the time-honored understanding that by far and away the most powerful factors affecting health and longevity are modifiable choices including the foods we eat and other aspects of lifestyle. So let’s move forward and explore this empowering information.

Antibiotic Exposure and Risk of Parkinson’s Disease in Finland: A Nationwide Case-Control Study

Journal of the International Parkinson and Movement Disorder Society October 28, 2019

The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson’s Disease

Frontiers in Nutrition May 14, 2019

Organic diet intervention significantly reduces urinary pesticide levels in U.S. children and adults

Environmental Research January 10, 2019

The vermiform appendix impacts the risk of developing Parkinson’s disease

SCIENCE TRANSLATIONAL MEDICINE October 31, 2018

Association between diabetes and subsequent Parkinson disease

Neurology July 10, 2018

Low-Fat Versus Ketogenic Diet in Parkinson’s Disease: A Pilot Randomized Controlled Trial

Movement Disorders March 5, 2018

The Central Nervous System and the Gut Microbiome

Cell November 3, 2016

Physical exercise induces hippocampal neurogenesis and prevents cognitive decline

October 13, 2016

Putative Role of Red wine Polyphenols against Brain Pathology in Alzheimer’s and Parkinson’s Disease

Frontiers in Nutrition August 12, 2016

N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson’s Disease: Preliminary Clinical and Cell Line Data

PLOS One June 16, 2016

The gut microbiota modulates host amino acid and glutathione metabolism in mice

Molecular Systems Biology October 16, 2015

Is Ginkgo biloba and/or a Multivitamin-multimineral Supplement a Therapeutic Option for Parkinson’s Disease?

Global Advances in Health and Medicine February 21, 2014

NRF2-regulation in brain health and disease: Implication of cerebral inflammation

Neuropharmacology November 8, 2013

Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson’s disease

NeuroToxicology March 18, 2013

Risk of Parkinson Disease Onset in Patients With Diabetes

Diabetes Care May 1, 2012

Diabetes and Risk of Parkinson’s Disease

DIABETES CARE April 7, 2011

The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson’s Disease

Parkinson's Disease January 3, 2011

High Prevalence of Hypovitaminosis D Status in Patients With Early Parkinson Disease

American Medical Association October 5, 2010

Serum Vitamin D and the Risk of Parkinson Disease

American Medical Association September 8, 2009

The transcription factor Nrf2 as a new therapeutic target in Parkinson’s disease

Informa Healthcare March 1, 2009